Voyager Therapeutics, Inc. (VYGR): Price and Financial Metrics

VYGR POWR Grades

• VYGR scores best on the Value dimension, with a Value rank ahead of 99.01% of US stocks.
• The strongest trend for VYGR is in Growth, which has been heading down over the past 177 days.
• VYGR's current lowest rank is in the Growth metric (where it is better than 2.12% of US stocks).

VYGR Stock Summary

• The ratio of debt to operating expenses for VOYAGER THERAPEUTICS INC is higher than it is for about only 0.22% of US stocks.
• Over the past twelve months, VYGR has reported earnings growth of -406.41%, putting it ahead of just 3.44% of US stocks in our set.
• Revenue growth over the past 12 months for VOYAGER THERAPEUTICS INC comes in at 124.58%, a number that bests 95.95% of the US stocks we're tracking.
• Stocks that are quantitatively similar to VYGR, based on their financial statements, market capitalization, and price volatility, are CRDF, PRTC, HYLN, LPCN, and MRSN.
• Visit VYGR's SEC page to see the company's official filings. To visit the company's web site, go to www.voyagertherapeutics.com.

VYGR Valuation Summary

• VYGR's EV/EBIT ratio is 4.6; this is 63.78% lower than that of the median Healthcare stock.
• Over the past 98 months, VYGR's EV/EBIT ratio has gone up 18.3.

Below are key valuation metrics over time for VYGR.

VYGR Growth Metrics

The 2 year net income to common stockholders growth rate now stands at -74.16%.
• Its 5 year net cashflow from operations growth rate is now at -122.66%.
• Its 5 year net income to common stockholders growth rate is now at 18.05%.

Over the past 33 months, VYGR's revenue has gone down $33,862,000.

The table below shows VYGR's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	70.529	10.93	-17.073
2022-06-30	30.925	6.427	-59.834
2022-03-31	31.57	2.195	-70.867
2021-12-31	37.415	-53.525	-71.197
2021-09-30	15.877	-86.697	-92.832
2021-06-30	132.238	-90.728	17.916

VYGR's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• VYGR has a Quality Grade of D, ranking ahead of 16.57% of graded US stocks.
• VYGR's asset turnover comes in at 0.071 -- ranking 290th of 681 Pharmaceutical Products stocks.
• JAGX, SGEN, and OTLC are the stocks whose asset turnover ratios are most correlated with VYGR.

The table below shows VYGR's key quality metrics over time.